Back to Surveys Diabetes Prevention Survey

A Survey for Adults with Diabetes and Parents of Children with Diabetes

A test taken from cord blood of newborns can determine the likelihood of developing Type 1 diabetes. Relatives (siblings or offspring) of Type 1 patients are at an increased risk of diabetes that varies depending on their HLA genotype and HLA haplotype sharing with the diabetic relative. Approximately 20-40% of the relatives with the HLA-DR3/4,DQB1*0302 genotype develop pre-diabetic autoimmunity in the first 2-3 years of life and an estimated 70% of those develop diabetes over the next 5 years.

This survey is now closed.

1.   I am:
  A parent of a diabetic child
A diabetic adult
2.   Would you participate in a trial to tell you your newborn's genetic risk?
3.   If yes and your child was at high risk, which of the following would you consider trying if offered in a prevention trial? Check all that apply.
    Giving low dose shots of insulin for a month followed by insulin shots weekly
Giving insulin through a nasal spray daily for several months
Giving oral insulin daily for several months
Giving vitamin supplements daily for several months
Giving breast milk as long as possible followed by a specialized formula until 8 months of age
Any of the above as recommended for my child by my specialist
Other or none of these

  Back to Surveys Return to the Top of This Page

Last Updated: Thursday August 29, 2002 20:59:46
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.